Evidence map›Paper›PMID 26061812›Full record

ArticlePloS one2015

Incomplete Restoration of Angiotensin II-Induced Renal Extracellular Matrix Deposition and Inflammation Despite Complete Functional Recovery in Rats.

Anne-Roos S Frenay, Saleh Yazdani, Miriam Boersema, Anne Marijn van der Graaf, Femke Waanders, Jacob van den Born, Gerjan J Navis, Harry van Goor

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anne-Roos S FrenayDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Saleh YazdaniDepartment of Nephrology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Miriam BoersemaDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Anne Marijn van der GraafDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands; Department of Obstetrics and Gynecology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Femke WaandersDepartment of Nephrology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Jacob van den BornDepartment of Nephrology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Gerjan J NavisDepartment of Nephrology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Harry van GoorDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some diseases associated with a temporary deterioration in kidney function and/or development of proteinuria show an apparently complete functional remission once the initiating trigger is removed. While it was earlier thought that a transient impairment of kidney function is harmless, accumulating evidence now suggests that these patients are more prone to developing renal failure later in life. We therefore sought to investigate to what extent renal functional changes, inflammation and collagen deposition are reversible after cessation of disease induction, potentially explaining residual sensitivity to damage. Using a rat model of Angiotensin II (Ang II)-induced hypertensive renal disease we show the development of severe hypertension (212 ± 10.43 vs. 146 ± 1.4 mmHg, p<0.001) and proteinuria (51.4 ± 6.3 vs. 14.7 ± 2.0 mg/24h, p<0.01) with declined creatinine clearance (2.0 ± 0.5 vs. 4.9 ± 0.6 mL/min, p<0.001) to occur after 3 weeks of Ang II infusion. At the structural level, Ang II infusion resulted in interstitial inflammation (18.8 ± 4.8 vs. 3.6 ± 0.5 number of macrophages, p<0.001), renal interstitial collagen deposition and lymphangiogenesis (4.1 ± 0.4 vs. 2.2 ± 0.4 number of lymph vessels, p<0.01). Eight weeks after cessation of Ang II, all clinical parameters, pre-fibrotic changes such as myofibroblast transformation and increase in lymph vessel number (lymphangiogenesis) returned to control values. However, glomerular desmin expression, glomerular and periglomerular macrophages and interstitial collagens remained elevated. These dormant abnormalities indicate that after transient renal function decline, inflammation and collagen deposition may persist despite normalization of the initiating pathophysiological stimulus perhaps rendering the kidney more vulnerable to further damage.

Indexed as

Angiotensin IIAnimalsCollagenDesminExtracellular MatrixHypertension, RenalInflammationKidneyMaleRatsRats, WistarAngiotensin IICollagenDesmin

Identifiers

PMID26061812
PMCPMC4464893
OpenAlexW2120832818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.